Anaphylaxis to a self-peptide in the absence of mast cells or histamine

Laboratory Investigation

Volumn 89, Issue 4, 2009, Pages 398-405

  Musio, Silvia ^a   Pedotti, Paola ^b   Mantegazza, Renato ^a   Ohtsu, Hiroshi ^c   Boon, Louis ^d   Steinman, Lawrence ^e   Galli, Stephen J ^e,f   Pedotti, Rosetta ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c TOHOKU UNIVERSITY   (Japan)

^d BIOCEROS   (Netherlands)

^e STANFORD UNIVERSITY   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaphylaxis; Experimental autoimmune encephalomyelitis; Histamine; IL 4; Mast cells; Self peptide

Indexed keywords

2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; HISTAMINE; HISTIDINE DECARBOXYLASE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 4; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PERTUSSIS TOXIN; THROMBOCYTE ACTIVATING FACTOR; TRIPROLIDINE;

ADJUVANT THERAPY; ALLERGIC ENCEPHALOMYELITIS; ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BODY TEMPERATURE; CHEMOPROPHYLAXIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MAST CELL; MONOTHERAPY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 63449141923     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.4     Document Type: Article

References (36)

1. Steinman L. Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year. J Exp Med 2003;197:1065-1071.
2. Fontoura P, Garren H, Steinman L. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides. Int Rev Immunol 2005;24:415-446.
3. McDevitt H. Specific antigen vaccination to treat autoimmune disease. Proc Natl Acad Sci USA 2004;101(Suppl 2):14627-14630.
4. Lichtenegger FS, Kuerten S, Faas S, et al. Dissociation of experimental allergic encephalomyelitis protective effect and allergic side reactions in tolerization with neuroantigen. J Immunol 2007;178:4749-4756.
5. Pedotti R, DeVoss JJ, Youssef S, et al. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc Natl Acad Sci USA 2003;100:1867-1872.
6. Pedotti R, Mitchell D, Wedemeyer J, et al. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat Immunol 2001;2:216-222.
7. Scabeni S, Lapilla M, Musio S, et al. CD4+CD25+ regulatory T cells specific for a thymus-expressed antigen prevent the development of anaphylaxis to self. J Immunol 2008;180:4433-4440.
8. Smith CE, Eagar TN, Strominger JL, et al. Differential induction of IgE-mediated anaphylaxis after soluble vs cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2005;102:9595-9600.
9. Kappos L, Comi G, Panitch H, et al. Induction of a nonencephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. Nat Med 2000;6:1176-1182.
10. Aharoni R, Teitelbaum D, Arnon R, et al. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking. Proc Natl Acad Sci USA 1999;96:634-639.
11. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002;2:773-786.
12. Miyajima I, Dombrowicz D, Martin TR, et al. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest 1997;99:901-914.
13. Finkelman FD, Rothenberg ME, Brandt EB, et al. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 2005;115:449-457; quiz 458.
14. Strait RT, Morris SC, Yang M, et al. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 2002;109:658-668.
15. Tsujimura Y, Obata K, Mukai K, et al. Basophils play a pivotal role in immunoglobulin-g-mediated but not immunoglobulin-e-mediated systemic anaphylaxis. Immunity 2008;28:581-589.
16. Musio S, Gallo B, Scabeni S, et al. A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J Immunol 2006;176: 17-26.
17. Bettelli E, Das MP, Howard ED, et al. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 1998;161:3299-3306.
18. Liblau R, Steinman L, Brocke S. Experimental autoimmune encephalomyelitis in IL-4-deficient mice. Int Immunol 1997;9:799-803.
19. Secor VH, Secor WE, Gutekunst CA, et al. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 2000;191:813-822.
20. Takeishi T, Martin TR, Katona IM, et al. Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses. J Clin Invest 1991;88:598-608.
21. Ohtsu H, Tanaka S, Terui T, et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 2001;502:53-56.
22. Makabe-Kobayashi Y, Hori Y, Adachi T, et al. The control effect of histamine on body temperature and respiratory function in IgEdependent systemic anaphylaxis. J Allergy Clin Immunol 2002;110:298-303.
23. Stevens TL, Bossie A, Sanders VM, et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988;334:255-258.
24. Faquim-Mauro EL, Coffman RL, Abrahamsohn IA, et al. Cutting edge: mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. J Immunol 1999;163:3572-3576.
25. Kopf M, Le Gros G, Bachmann M, et al. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362:245-248.
26. Kuhn R, Rajewsky K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science 1991;254:707-710.
27. McKenzie GJ, Fallon PG, Emson CL, et al. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999;189:1565-1572.
28. Denzel A, Maus UA, Rodriguez Gomez M, et al. Basophils enhance immunological memory responses. Nat Immunol 2008;9:733-742.
29. Grimbaldeston MA, Chen CC, Piliponsky AM, et al. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005;167:835-848.
30. Lantz CS, Boesiger J, Song CH, et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998;392:90-93.
31. Mukai K, Matsuoka K, Taya C, et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005;23:191-202.
32. Obata K, Mukai K, Tsujimura Y, et al. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 2007;110:913-920.
33. Liu E, Moriyama H, Abiru N, et al. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. J Clin Invest 2002;110:1021-1027.
34. Rauschka H, Farina C, Sator P, et al. Severe anaphylactic reaction to glatiramer acetate with specific IgE. Neurology 2005;64:1481-1482.
35. Aalberse RC, van der Gaag R, van Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 1983;130:722-726.
36. Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergenspecific immunotherapy. Nat Rev Immunol 2006;6:761-771.